148 related articles for article (PubMed ID: 28349821)
21. NUCKS nuclear elevated expression indicates progression and prognosis of ovarian cancer.
Shi C; Qin L; Gao H; Gu L; Yang C; Liu H; Liu T
Tumour Biol; 2017 Sep; 39(9):1010428317714631. PubMed ID: 28877654
[TBL] [Abstract][Full Text] [Related]
22. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
Yavuzcan A; Baloglu A; Cetinkaya B
Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
[TBL] [Abstract][Full Text] [Related]
23. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.
Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ
Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166
[TBL] [Abstract][Full Text] [Related]
25. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
[TBL] [Abstract][Full Text] [Related]
26. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
[TBL] [Abstract][Full Text] [Related]
27. Reduced bikunin gene expression as a factor of poor prognosis in ovarian carcinoma.
Tanaka Y; Kobayashi H; Suzuki M; Kanayama N; Suzuki M; Yamakawa T; Morishita H; Terao T
Cancer; 2003 Jul; 98(2):424-30. PubMed ID: 12872365
[TBL] [Abstract][Full Text] [Related]
28. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.
Djordjevic B; Malpica A
Am J Surg Pathol; 2010 Jan; 34(1):1-9. PubMed ID: 19898226
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of Growth-Related Oncogene-β Is Associated with Tumorigenesis, Metastasis, and Poor Prognosis in Ovarian Cancer.
Ye Q; Zhai X; Wang W; Zhang S; Zhu H; Wang D; Wang C
Dis Markers; 2015; 2015():387382. PubMed ID: 26063953
[TBL] [Abstract][Full Text] [Related]
30. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
31. Mitotic arrest deficient-like 1 is correlated with poor prognosis in small-cell lung cancer after surgical resection.
Li D; Meng Q; Zhang H; Feng T; Liu M; Cai L
Tumour Biol; 2016 Apr; 37(4):4393-8. PubMed ID: 26499943
[TBL] [Abstract][Full Text] [Related]
32. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of WWOX protein in epithelial ovarian cancer: a clinicopathologic and immunohistochemical study.
Lan C; Chenggang W; Yulan B; Xiaohui D; Junhui Z; Xiao W
Int J Gynecol Pathol; 2012 Mar; 31(2):125-32. PubMed ID: 22317867
[TBL] [Abstract][Full Text] [Related]
34. Lymph node metastasis in stage I epithelial ovarian cancer.
Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
[TBL] [Abstract][Full Text] [Related]
35. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma].
Yang YQ; Li JC
Ai Zheng; 2006 Jun; 25(6):713-7. PubMed ID: 16764766
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between SLP-2 expression and prognosis in laryngeal squamous cell carcinoma and mammary invasive carcinoma].
Cao WF; Zhang LY; Zhang B; Liu MB; Liu ZH; Sun BC
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):332-7. PubMed ID: 20654157
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of δ-like ligand 4 contributes significantly to axillary lymph node metastasis and predicts postoperative outcome in breast cancer.
Xiao M; Yang S; Ning X; Huang Y
Hum Pathol; 2014 Nov; 45(11):2302-10. PubMed ID: 25260720
[TBL] [Abstract][Full Text] [Related]
38. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
39. Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.
Liu L; Zeng Z; Yi J; Zuo L; Lv J; Yuan J; Lin Z; Luo R; Feng X
Cancer Biomark; 2019; 24(2):213-221. PubMed ID: 30614797
[TBL] [Abstract][Full Text] [Related]
40. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
